News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Dynogen Pharmaceuticals, Inc. Files for Bankruptcy
February 25, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Dynogen Pharmaceuticals Inc. filed this week to liquidate under Chapter 7 of the U.S. bankruptcy code — almost a year after a deal to go public fell through.
Twitter
LinkedIn
Facebook
Email
Print
Bankruptcy
MORE ON THIS TOPIC
Layoff Tracker
Charles River, Thermo Fisher Lay Off Staff Amid Site Closures
February 6, 2026
·
51 min read
·
BioSpace Editorial Staff
Insights
Programmable RNA 2.0: Beyond the First mRNA Revolution
February 5, 2026
·
1 min read
·
Jennifer Smith-Parker
Deals
Roche Keeps the Deals Coming With up to $1.7B SangeneBio RNAi Pact
February 3, 2026
·
1 min read
·
Tristan Manalac
Deals
Moderna Teams With Recordati on Rare Disease mRNA Therapy for up to $160M
January 30, 2026
·
1 min read
·
Annalee Armstrong
